Angiogenic properties

Angiogenic properties refer to the capacity of a biological agent or environment to stimulate angiogenesis, the physiological process through which new blood vessels form from pre-existing vasculature (NIH National Cancer Institute). This is a multi-step process involving endothelial cell activation, proliferation, and migration, primarily regulated by pro-angiogenic factors such as Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factor (FGF) (PubMed: 22019052). While essential for normal development and wound healing, the dysregulation of angiogenic properties is a hallmark of several diseases; for instance, tumors exploit these properties to ensure a nutrient supply for growth and metastasis (Hanahan & Weinberg, Cell 2011). In clinical practice, therapeutic interventions often focus on inhibiting these properties in oncology and ophthalmology using anti-angiogenic drugs like bevacizumab or ranibizumab. Conversely, enhancing angiogenic properties is a therapeutic goal in regenerative medicine and the treatment of ischemic cardiovascular diseases.

Other names

AngiogenesisNeovascularizationPro-angiogenic activityBlood vessel formation

Not applicable; 'Angiogenic properties' describes a biological process or phenotype rather than a specific molecular target. Drugs intended to modulate these properties typically target growth factors like VEGF or their associated receptors (VEGFR).